Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Imaging spectrum of Bing-Neel syndrome: how can a radiologist recognise this rare neurological complication of Waldenström's macroglobulinemia?

Fitsiori A, Fornecker LM, Simon L, Karentzos A, Galanaud D, Outteryck O, Vermersch P, Pruvo JP, Gerardin E, Lebrun-Frenay C, Lafitte F, Cottier JP, Clerc C, de Seze J, Dietemann JL, Kremer S.

Eur Radiol. 2018 Jun 19. doi: 10.1007/s00330-018-5543-7. [Epub ahead of print]

PMID:
29922935
2.

MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study.

Tourbah A, Gout O, Vighetto A, Deburghgraeve V, Pelletier J, Papeix C, Lebrun-Frenay C, Labauge P, Brassat D, Toosy A, Laplaud DA, Outteryck O, Moreau T, Debouverie M, Clavelou P, Heinzlef O, De Sèze J, Defer G, Sedel F, Arndt C.

CNS Drugs. 2018 Jul;32(7):661-672. doi: 10.1007/s40263-018-0528-2.

3.

Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy.

Hodel J, Bapst B, Outteryck O, Verclytte S, Deramecourt V, Benadjaoud MA, Pruvo JP, Vermersch P, Leclerc X.

Mult Scler. 2018 Jan 1:1352458517750765. doi: 10.1177/1352458517750765. [Epub ahead of print]

PMID:
29343163
4.

Proinflammatory B-cell profile in the early phases of MS predicts an active disease.

Guerrier T, Labalette M, Launay D, Lee-Chang C, Outteryck O, Lefèvre G, Vermersch P, Dubucquoi S, Zéphir H.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 22;5(2):e431. doi: 10.1212/NXI.0000000000000431. eCollection 2018 Mar.

5.

[Myelitis as a differential diagnosis of spinal cord tumors].

Vermersch P, Outteryck O, Ferriby D, Zéphir H.

Neurochirurgie. 2017 Nov;63(5):349-355. doi: 10.1016/j.neuchi.2017.06.004. Epub 2017 Nov 6. French.

PMID:
29102045
6.

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.

Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, Martinez-Lapiscina EH, Green AJ, Kardon R, Outteryck O, Paul F, Schippling S, Vermersch P, Villoslada P, Balk LJ; ERN-EYE IMSVISUAL.

Lancet Neurol. 2017 Oct;16(10):797-812. doi: 10.1016/S1474-4422(17)30278-8. Epub 2017 Sep 12. Review.

PMID:
28920886
7.

Neuralgic amyotrophy triggered by hepatitis E virus: a particular phenotype.

Scanvion Q, Perez T, Cassim F, Outteryck O, Lanteri A, Hatron PY, Lambert M, Morell-Dubois S.

J Neurol. 2017 Apr;264(4):770-780. doi: 10.1007/s00415-017-8433-z. Epub 2017 Feb 28. Review.

8.

Continuous hemifacial myokymia as the revealing symptom of demyelinating disease of the CNS.

London F, Hadhoum N, Zéphir H, Vermersch P, Outteryck O.

Mult Scler Relat Disord. 2017 Jan;11:10-11. doi: 10.1016/j.msard.2016.11.001. Epub 2016 Nov 9.

PMID:
28104248
9.

Autoimmune cerebellar ataxia with glutamic acid decarboxylase 65 antibodies associated with central vestibular symptoms.

London F, Hadhoum N, Zéphir H, Outteryck O, Vermersch P.

Acta Neurol Belg. 2017 Sep;117(3):775-776. doi: 10.1007/s13760-016-0733-z. Epub 2016 Dec 17. No abstract available.

PMID:
27988832
10.

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.

Havla J, Kümpfel T, Schinner R, Spadaro M, Schuh E, Meinl E, Hohlfeld R, Outteryck O.

J Neurol. 2017 Jan;264(1):139-151. doi: 10.1007/s00415-016-8333-7. Epub 2016 Nov 14.

PMID:
27844165
11.

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy.

Pignolet B, Schwab N, Schneider-Hohendorf T, Bucciarelli F, Biotti D, Averseng-Peaureaux D, Outteryck O, Ongagna JC, de Sèze J, Brochet B, Ouallet JC, Debouverie M, Pittion S, Defer G, Derache N, Hautecoeur P, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Berger E, Pelletier J, Rico A, Zéphir H, Laplaud D, Wiertlewski S, Camu W, Thouvenot E, Casez O, Moreau T, Fromont A, Vukusic S, Papeix C, Vermersch P, Comabella M, Lebrun-Frenay C, Wiendl H, Brassat D; BIONAT, SFSEP, and BEST-MS networks.

Neurology. 2016 Dec 6;87(23):2491-2494. Epub 2016 Nov 4. No abstract available.

PMID:
27815407
12.

Late-onset of Alpers-Huttenlocher syndrome: an unusual cause of refractory epilepsy and liver failure.

London F, Hadhoum N, Outteryck O, Vermersch P, Zéphir H.

Acta Neurol Belg. 2017 Mar;117(1):399-401. doi: 10.1007/s13760-016-0672-8. Epub 2016 Jul 15. No abstract available.

PMID:
27422324
13.

Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence.

Hodel J, Badr S, Outteryck O, Lebert P, Chechin D, Benadjaoud MA, Pruvo JP, Vermersch P, Leclerc X.

Eur Radiol. 2017 Feb;27(2):637-641. doi: 10.1007/s00330-016-4416-1. Epub 2016 May 27.

PMID:
27229340
14.

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.

Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P; IMSVISUAL consortium.

Lancet Neurol. 2016 May;15(6):574-84. doi: 10.1016/S1474-4422(16)00068-5. Epub 2016 Mar 18.

PMID:
27011339
15.

Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML.

Hodel J, Darchis C, Outteryck O, Verclytte S, Deramecourt V, Lacour A, Zins M, Pruvo JP, Vermersch P, Leclerc X.

Neurology. 2016 Apr 19;86(16):1516-23. doi: 10.1212/WNL.0000000000002586. Epub 2016 Mar 23.

PMID:
27009257
16.

Natalizumab in relapsing-remitting multiple sclerosis.

Outteryck O.

Expert Rev Neurother. 2016 May;16(5):471-81. doi: 10.1586/14737175.2016.1169924. Epub 2016 Apr 8. Review.

PMID:
27008031
17.

REPLY.

Hodel J, Outteryck O, Verclytte S, Deramecourt V, Lacour A, Pruvo JP, Vermersch P, Leclerc X.

AJNR Am J Neuroradiol. 2016 Feb;37(2):E12. doi: 10.3174/ajnr.A4634. Epub 2015 Dec 3. No abstract available.

18.

Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR Imaging.

Hodel J, Outteryck O, Dubron C, Dutouquet B, Benadjaoud MA, Duhin E, Verclytte S, Zins M, Luciani A, Rahmouni A, Pruvo JP, Vermersch P, Leclerc X.

Radiology. 2016 Mar;278(3):863-72. doi: 10.1148/radiol.2015150673. Epub 2015 Oct 5.

PMID:
26436861
19.

Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.

Hodel J, Outteryck O, Verclytte S, Deramecourt V, Lacour A, Pruvo JP, Vermersch P, Leclerc X.

AJNR Am J Neuroradiol. 2015 Dec;36(12):2296-302. doi: 10.3174/ajnr.A4436. Epub 2015 Aug 27.

20.

Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss.

Hadhoum N, Hodel J, Defoort-Dhellemmes S, Duhamel A, Drumez E, Zéphir H, Pruvo JP, Leclerc X, Vermersch P, Outteryck O.

Mult Scler. 2016 Apr;22(5):649-58. doi: 10.1177/1352458515598021. Epub 2015 Jul 30.

PMID:
26227005
21.

Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability.

Zéphir H, Bernard-Valnet R, Lebrun C, Outteryck O, Audoin B, Bourre B, Pittion S, Wiertlewski S, Ouallet JC, Neau JP, Ciron J, Clavelou P, Marignier R, Brassat D.

J Neurol. 2015 Oct;262(10):2329-35. doi: 10.1007/s00415-015-7852-y. Epub 2015 Jul 21.

PMID:
26194198
22.

Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life.

Allart E, Benoit A, Blanchard-Dauphin A, Tiffreau V, Thevenon A, Zephir H, Outteryck O, Lacour A, Vermersch P.

J Neurol. 2015 Aug;262(8):1936-45. doi: 10.1007/s00415-015-7797-1. Epub 2015 Jun 5.

PMID:
26041616
23.

A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.

Outteryck O, Majed B, Defoort-Dhellemmes S, Vermersch P, Zéphir H.

Mult Scler. 2015 Dec;21(14):1781-93. doi: 10.1177/1352458515578888. Epub 2015 Mar 31.

PMID:
25828758
24.

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

Ayrignac X, Carra-Dalliere C, Menjot de Champfleur N, Denier C, Aubourg P, Bellesme C, Castelnovo G, Pelletier J, Audoin B, Kaphan E, de Seze J, Collongues N, Blanc F, Chanson JB, Magnin E, Berger E, Vukusic S, Durand-Dubief F, Camdessanche JP, Cohen M, Lebrun-Frenay C, Brassat D, Clanet M, Vermersch P, Zephir H, Outteryck O, Wiertlewski S, Laplaud DA, Ouallet JC, Brochet B, Goizet C, Debouverie M, Pittion S, Edan G, Deburghgraeve V, Le Page E, Verny C, Amati-Bonneau P, Bonneau D, Hannequin D, Guyant-Maréchal L, Derache N, Defer GL, Moreau T, Giroud M, Guennoc AM, Clavelou P, Taithe F, Mathis S, Neau JP, Magy L, Devoize JL, Bataillard M, Masliah-Planchon J, Dorboz I, Tournier-Lasserve E, Levade T, Boespflug Tanguy O, Labauge P.

Brain. 2015 Feb;138(Pt 2):284-92. doi: 10.1093/brain/awu353. Epub 2014 Dec 19.

PMID:
25527826
25.

Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study.

Hodel J, Outteryck O, Bocher AL, Zéphir H, Lambert O, Benadjaoud MA, Chechin D, Pruvo JP, Vermersch P, Leclerc X.

Eur Radiol. 2014 Dec;24(12):3069-75. doi: 10.1007/s00330-014-3342-3. Epub 2014 Aug 23.

PMID:
25149294
26.

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.

Schippling S, Balk LJ, Costello F, Albrecht P, Balcer L, Calabresi PA, Frederiksen JL, Frohman E, Green AJ, Klistorner A, Outteryck O, Paul F, Plant GT, Traber G, Vermersch P, Villoslada P, Wolf S, Petzold A.

Mult Scler. 2015 Feb;21(2):163-70. doi: 10.1177/1352458514538110. Epub 2014 Jun 16.

PMID:
24948688
27.

[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects].

Lionnet C, Carra C, Ayrignac X, Levade T, Gayraud D, Castelnovo G, Besson G, Androdias G, Vukusic S, Confavreux C, Zaenker C, De Seze J, Collongues N, Blanc F, Tranchant C, Wallon D, Hannequin D, Gerdelat-Mas A, Brassat D, Clanet M, Zephir H, Outteryck O, Vermersch P, Labauge P.

Rev Neurol (Paris). 2014 Jun-Jul;170(6-7):445-53. doi: 10.1016/j.neurol.2014.01.675. Epub 2014 Apr 16. French.

PMID:
24746394
28.

Does fatigue complaint reflect memory impairment in multiple sclerosis?

Jougleux-Vie C, Duhin E, Deken V, Outteryck O, Vermersch P, Zéphir H.

Mult Scler Int. 2014;2014:692468. doi: 10.1155/2014/692468. Epub 2014 Mar 2.

29.

Extensive myelitis associated with anti-NMDA receptor antibodies.

Outteryck O, Baille G, Hodel J, Giroux M, Lacour A, Honnorat J, Zéphir H, Vermersch P.

BMC Neurol. 2013 Dec 27;13:211. doi: 10.1186/1471-2377-13-211.

30.

Accuracy of postcontrast 3D turbo spin-echo MR sequence for the detection of enhanced inflammatory lesions in patients with multiple sclerosis.

Hodel J, Outteryck O, Ryo E, Bocher AL, Lambert O, Chéchin D, Zéphir H, Lacour A, Pruvo JP, Vermersch P, Leclerc X.

AJNR Am J Neuroradiol. 2014 Mar;35(3):519-23. doi: 10.3174/ajnr.A3795. Epub 2013 Nov 7.

31.

[Natalizumab as induction therapy in multiple sclerosis].

Corlobé A, Charif M, Mania A, Outteryck O, de Sèze J, Labauge P.

Rev Neurol (Paris). 2014 Jan;170(1):2-5. doi: 10.1016/j.neurol.2013.06.004. Epub 2013 Oct 11. Review. French.

PMID:
24125463
32.

JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.

Outteryck O, Zéphir H, Salleron J, Ongagna JC, Etxeberria A, Collongues N, Lacour A, Fleury MC, Blanc F, Giroux M, de Seze J, Vermersch P.

Mult Scler. 2014 Jun;20(7):822-9. doi: 10.1177/1352458513505353. Epub 2013 Sep 26.

PMID:
24072722
33.

[Anti-Hu antibody syndrome: diagnostic and therapeutic difficulties].

Leroy T, Porte H, Rousselot C, Taieb S, Outteryck O, Dansin É.

Rev Mal Respir. 2013 Sep;30(7):563-6. doi: 10.1016/j.rmr.2013.03.004. Epub 2013 May 9. French.

PMID:
24034461
34.

3D mapping of cerebrospinal fluid local volume changes in patients with hydrocephalus treated by surgery: preliminary study.

Hodel J, Besson P, Rahmouni A, Petit E, Lebret A, Grandjacques B, Outteryck O, Benadjaoud MA, Maraval A, Luciani A, Pruvo JP, Decq P, Leclerc X.

Eur Radiol. 2014 Jan;24(1):136-42. doi: 10.1007/s00330-013-2990-z. Epub 2013 Aug 27.

PMID:
23979107
35.

Mixed connective tissue disease presenting as trigeminal neuropathy.

Hamoir B, Giroux M, Outteryck O, Launay D, Vermersch P.

Acta Neurol Belg. 2014 Sep;114(3):245-6. doi: 10.1007/s13760-013-0226-2. Epub 2013 Aug 1. No abstract available.

PMID:
23903962
36.

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.

Outteryck O, Ongagna JC, Brochet B, Rumbach L, Lebrun-Frenay C, Debouverie M, Zéphir H, Ouallet JC, Berger E, Cohen M, Pittion S, Laplaud D, Wiertlewski S, Cabre P, Pelletier J, Rico A, Defer G, Derache N, Camu W, Thouvenot E, Moreau T, Fromont A, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Casez O, Hautecoeur P, Papeix C, Lubetzki C, Fontaine B, Couturier N, Bohossian N, Clanet M, Vermersch P, de Sèze J, Brassat D; BIONAT Network,; CFSEP.

Eur J Neurol. 2014;21(1):40-8. doi: 10.1111/ene.12204. Epub 2013 Jun 12.

PMID:
23895407
37.

Fluid-attenuated inversion recovery vascular hyperintensities are not visible using 3D CUBE FLAIR sequence.

Hodel J, Leclerc X, Rodallec M, Gerber S, Blanc R, Outteryck O, Benadjaoud S, Rabrait C, Zuber M, Pruvo JP, Zins M.

Eur Radiol. 2013 Jul;23(7):1963-9. doi: 10.1007/s00330-013-2796-z. Epub 2013 Mar 15.

PMID:
23494495
38.

Longitudinal follow-up of vision in a neuromyelitis optica cohort.

Bouyon M, Collongues N, Zéphir H, Ballonzoli L, Jeanjean L, Lebrun C, Chanson J, Blanc F, Fleury M, Outteryck O, Defoort S, Labauge P, Vermersch P, Speeg C, De Seze J.

Mult Scler. 2013 Sep;19(10):1320-2. doi: 10.1177/1352458513476562. Epub 2013 Feb 14.

PMID:
23413296
39.

MRI of myelitis.

Hodel J, Outteryck O, Jissendi P, Zins M, Leclerc X, Pruvo JP.

JBR-BTR. 2012 Jul-Aug;95(4):270-6. Review. No abstract available.

PMID:
23019999
40.

Pulse-triggered DTI sequence with reduced FOV and coronal acquisition at 3T for the assessment of the cervical spinal cord in patients with myelitis.

Hodel J, Besson P, Outteryck O, Zéphir H, Ducreux D, Monnet A, Chéchin D, Zins M, Rodallec M, Pruvo JP, Vermersch P, Leclerc X.

AJNR Am J Neuroradiol. 2013 Mar;34(3):676-82. doi: 10.3174/ajnr.A3254. Epub 2012 Aug 23.

41.

The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas?

Phan-Ba R, Belachew S, Outteryck O, Moonen G, Sindic C, Vokaer M, Vermersch P.

Neurology. 2012 Sep 4;79(10):1067-9. doi: 10.1212/WNL.0b013e31826846b4. Epub 2012 Aug 22. No abstract available.

PMID:
22914844
42.

Methionine synthase deficiency: a rare cause of adult-onset leukoencephalopathy.

Outteryck O, de Sèze J, Stojkovic T, Cuisset JM, Dobbelaere D, Delalande S, Lacour A, Cabaret M, Lepoutre AC, Deramecourt V, Zéphir H, Fowler B, Vermersch P.

Neurology. 2012 Jul 24;79(4):386-8. doi: 10.1212/WNL.0b013e318260451b. Epub 2012 Jul 11. No abstract available.

PMID:
22786600
43.

Cranial nerve involvement in infratentorial progressive multifocal leukoencephalopathy.

Hodel J, Outteryck O, Zéphir H, Rodallec M, Zins M, Vermersch P, Leclerc X.

Neurology. 2012 Jul 3;79(1):104-5. doi: 10.1212/WNL.0b013e31825dce72. No abstract available.

PMID:
22753446
44.

Anti-JCV antibody prevalence in a French cohort of MS patients under natalizumab therapy.

Outteryck O, Ongagna JC, Duhamel A, Zéphir H, Collongues N, Lacour A, Fleury MC, Berteloot AS, Blanc F, Giroux M, Vermersch P, de Sèze J.

J Neurol. 2012 Nov;259(11):2293-8. doi: 10.1007/s00415-012-6487-5. Epub 2012 Apr 12.

PMID:
22527227
45.

Long-term follow-up of acute partial transverse myelitis.

Bourre B, Zéphir H, Ongagna JC, Cordonnier C, Collongues N, Debette S, Fleury MC, Outteryck O, Hannequin D, Vermersch P, de Seze J.

Arch Neurol. 2012 Mar;69(3):357-62. doi: 10.1001/archneurol.2011.949. Erratum in: Arch Neurol. 2012 Jun;69(6):789. Outerryck, Olivier [corrected to Outteryck, Olivier].

PMID:
22410443
46.

Neuromyelitis optica and pregnancy.

Bourre B, Marignier R, Zéphir H, Papeix C, Brassat D, Castelnovo G, Collongues N, Vukusic S, Labauge P, Outteryck O, Fontaine B, Vermersch P, Confavreux C, de Seze J; NOMADMUS Study Group.

Neurology. 2012 Mar 20;78(12):875-9. doi: 10.1212/WNL.0b013e31824c466f. Epub 2012 Mar 7.

PMID:
22402855
47.

Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis.

Melin A, Outteryck O, Collongues N, Zéphir H, Fleury MC, Blanc F, Lacour A, Ongagna JC, Berteloot AS, Vermersch P, de Sèze J.

J Neurol. 2012 Jun;259(6):1215-21. doi: 10.1007/s00415-011-6339-8. Epub 2011 Dec 13.

PMID:
22160375
48.

High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.

Collongues N, Marignier R, Zéphir H, Blanc F, Vukusic S, Outteryck O, Fleury M, Ruet A, Borgel F, Thouvenot E, Moreau T, Defer G, Derache N, Pelletier J, Audoin B, Debouverie M, Labauge P, Gout O, Camu W, Brassat D, Brochet B, Vermersch P, Confavreux C, de Seze J.

Mult Scler. 2011 Jun;17(6):720-4. doi: 10.1177/1352458510396923. Epub 2011 Jan 14.

PMID:
21239412
49.

Evaluation of health-related quality of life, fatigue and depression in neuromyelitis optica.

Chanson JB, Zéphir H, Collongues N, Outteryck O, Blanc F, Fleury M, Vermersch P, de Seze J.

Eur J Neurol. 2011 Jun;18(6):836-41. doi: 10.1111/j.1468-1331.2010.03252.x. Epub 2010 Nov 18.

PMID:
21087360
50.

4H syndrome: a rare cause of leukodystrophy.

Outteryck O, Devos D, Jissendi P, Boespflug-Tanguy O, Hopes L, Renard D, Ferri J, Vermersch P, Labauge P.

J Neurol. 2010 Oct;257(10):1759-61. doi: 10.1007/s00415-010-5598-0. Epub 2010 May 30. No abstract available.

PMID:
20512583

Supplemental Content

Loading ...
Support Center